Mitotic kinases have therefore been a focus of attention for designing small molecule inhibitors of cancer: mammalian Aurora-A kinase received particular attention for cancer therapeutics not only through its mitotic functions but also nonmitotic functions such as its role in epithelial-mesenchymal transition [50]. Here, AURKA is linked to cancer.